AstraZeneca PLC/ GB0009895292 /
2023-01-10 11:32:02 AM | Chg. - | Volume | Bid1:02:11 PM | Ask1:02:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
134.55EUR | - | 9 Turnover: 1,208.50 |
-Bid Size: - | -Ask Size: - | 217.35 bill.EUR | - | - |
GlobeNewswire
04-01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...